A detailed history of First Trust Advisors LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 561,228 shares of ADMA stock, worth $9.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
561,228
Previous 723,582 22.44%
Holding current value
$9.77 Million
Previous $8.09 Million 38.68%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.21 - $20.03 $1.82 Million - $3.25 Million
-162,354 Reduced 22.44%
561,228 $11.2 Million
Q2 2024

Aug 13, 2024

BUY
$5.98 - $11.18 $4.33 Million - $8.09 Million
723,582 New
723,582 $8.09 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.